Ovarian cancer is the leading cause of death among gynecologic malignancies and despite
advances in treatment, more than 50% of all patients will experience recurrence, resulting in …

OBJECTIVE: Ovarian cancer is one of the most deadly human cancers, resulting in over
15,000 deaths in the US each year. A reliable method that could predict disease outcome …

Serous ovarian cancer is a major gynecologic malignancy with a poor 5‑year survival rate.
However, little is known regarding the behavior and genetics of ovarian tumorigenesis …

Background MicroRNA (miRNA) expression is known to be deregulated in ovarian
carcinomas. However, limited data is available about the miRNA expression pattern for the …

Ovarian cancer (OC) is a highly malignant disease that seriously threatens women's health
and poses challenges for clinicians. MicroRNAs (miRNAs) have recently been intensively …

Ovarian cancer remains a leading cause of morbidity and mortality, with little change in
survival rates over the past 30 years. Research in the molecular biology underlying the …

Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …

Abstract 4514 Introduction: MicroRNAs (miRNAs) are non-protein-coding, endogenous,
small RNAs that can bind complementary mRNA to modulate gene expression and protein …

MicroRNAs (miRNAs) are small non‐coding RNAs that exert a regulatory effect post‐
transcriptionally by binding target mRNAs and inhibiting gene translation. miRNA …

Epithelial ovarian cancer (EOC) is a complex disease, with multiple histological subtypes
recognized. There have been major advances in the understanding of the cellular and …